Annual FCF
-$15.30 M
-$1.25 M-8.90%
31 December 2023
Summary:
Arcadia Biosciences annual free cash flow is currently -$15.30 million, with the most recent change of -$1.25 million (-8.90%) on 31 December 2023. During the last 3 years, it has risen by +$11.58 million (+43.07%). RKDA annual FCF is now -55.40% below its all-time high of -$9.85 million, reached on 31 December 2013.RKDA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$1.75 M
+$707.00 K+28.75%
30 September 2024
Summary:
Arcadia Biosciences quarterly free cash flow is currently -$1.75 million, with the most recent change of +$707.00 thousand (+28.75%) on 30 September 2024. Over the past year, it has increased by +$2.39 million (+57.73%). RKDA quarterly FCF is now at all-time high.RKDA Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$11.58 M
+$1.13 M+8.91%
30 September 2024
Summary:
Arcadia Biosciences TTM free cash flow is currently -$11.58 million, with the most recent change of +$1.13 million (+8.91%) on 30 September 2024. Over the past year, it has increased by +$3.72 million (+24.32%). RKDA TTM FCF is now -444.64% below its all-time high of -$2.13 million, reached on 31 March 2014.RKDA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RKDA Free Cash Flow Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | +57.7% | +24.3% |
3 y3 years | +43.1% | +74.0% | +56.9% |
5 y5 years | +18.1% | +68.8% | +38.0% |
RKDA Free Cash Flow High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -8.9% | +43.1% | at high | +74.0% | at high | +56.9% |
5 y | 5 years | -8.9% | +53.0% | at high | +82.6% | at high | +64.4% |
alltime | all time | -55.4% | +53.0% | at high | +82.6% | -444.6% | +64.4% |
Arcadia Biosciences Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$1.75 M(-28.8%) | -$11.58 M(-8.9%) |
June 2024 | - | -$2.46 M(-23.7%) | -$12.71 M(-15.6%) |
Mar 2024 | - | -$3.22 M(-22.2%) | -$15.06 M(-1.6%) |
Dec 2023 | -$15.30 M(+8.9%) | -$4.14 M(+43.7%) | -$15.30 M(+13.0%) |
Sept 2023 | - | -$2.88 M(-39.9%) | -$13.54 M(-3.5%) |
June 2023 | - | -$4.80 M(+38.6%) | -$14.02 M(+11.4%) |
Mar 2023 | - | -$3.47 M(+45.5%) | -$12.59 M(-10.4%) |
Dec 2022 | -$14.05 M(-47.7%) | -$2.38 M(-29.3%) | -$14.05 M(-23.7%) |
Sept 2022 | - | -$3.37 M(0.0%) | -$18.41 M(-21.7%) |
June 2022 | - | -$3.37 M(-31.6%) | -$23.52 M(-11.6%) |
Mar 2022 | - | -$4.92 M(-27.0%) | -$26.61 M(-1.0%) |
Dec 2021 | -$26.88 M(-17.4%) | -$6.75 M(-20.4%) | -$26.88 M(-1.1%) |
Sept 2021 | - | -$8.47 M(+31.2%) | -$27.18 M(+4.9%) |
June 2021 | - | -$6.46 M(+24.4%) | -$25.91 M(-6.5%) |
Mar 2021 | - | -$5.19 M(-26.3%) | -$27.70 M(-14.9%) |
Dec 2020 | -$32.55 M(+74.3%) | -$7.05 M(-2.2%) | -$32.55 M(+4.6%) |
Sept 2020 | - | -$7.21 M(-12.6%) | -$31.12 M(+10.2%) |
June 2020 | - | -$8.25 M(-17.9%) | -$28.23 M(+14.4%) |
Mar 2020 | - | -$10.05 M(+79.1%) | -$24.67 M(+32.1%) |
Dec 2019 | -$18.68 M | -$5.61 M(+29.9%) | -$18.68 M(+17.3%) |
Sept 2019 | - | -$4.32 M(-7.8%) | -$15.92 M(+1.8%) |
June 2019 | - | -$4.69 M(+15.5%) | -$15.64 M(+2.3%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2019 | - | -$4.06 M(+42.1%) | -$15.29 M(+10.1%) |
Dec 2018 | -$13.88 M(-1.2%) | -$2.86 M(-29.3%) | -$13.88 M(+1.2%) |
Sept 2018 | - | -$4.04 M(-6.8%) | -$13.71 M(+13.7%) |
June 2018 | - | -$4.34 M(+63.6%) | -$12.05 M(-0.4%) |
Mar 2018 | - | -$2.65 M(-1.3%) | -$12.11 M(-13.8%) |
Dec 2017 | -$14.04 M(-18.8%) | -$2.69 M(+12.6%) | -$14.04 M(-10.2%) |
Sept 2017 | - | -$2.38 M(-45.7%) | -$15.64 M(-9.1%) |
June 2017 | - | -$4.39 M(-4.3%) | -$17.22 M(+2.0%) |
Mar 2017 | - | -$4.59 M(+7.0%) | -$16.88 M(-2.3%) |
Dec 2016 | -$17.29 M(+13.3%) | -$4.29 M(+8.4%) | -$17.29 M(+1.6%) |
Sept 2016 | - | -$3.96 M(-2.4%) | -$17.02 M(-3.9%) |
June 2016 | - | -$4.05 M(-18.8%) | -$17.70 M(+0.3%) |
Mar 2016 | - | -$4.99 M(+24.3%) | -$17.65 M(+15.6%) |
Dec 2015 | -$15.26 M(+2.2%) | -$4.02 M(-13.4%) | -$15.26 M(+8.9%) |
Sept 2015 | - | -$4.64 M(+16.0%) | -$14.01 M(+6.8%) |
June 2015 | - | -$4.00 M(+53.6%) | -$13.11 M(-14.9%) |
Mar 2015 | - | -$2.60 M(-5.8%) | -$15.41 M(+3.2%) |
Dec 2014 | -$14.94 M(+51.7%) | -$2.77 M(-26.1%) | -$14.94 M(+22.7%) |
Sept 2014 | - | -$3.74 M(-40.6%) | -$12.17 M(+44.4%) |
June 2014 | - | -$6.30 M(+196.4%) | -$8.43 M(+296.4%) |
Mar 2014 | - | -$2.13 M | -$2.13 M |
Dec 2013 | -$9.85 M(-0.3%) | - | - |
Dec 2012 | -$9.87 M | - | - |
FAQ
- What is Arcadia Biosciences annual free cash flow?
- What is the all time high annual FCF for Arcadia Biosciences?
- What is Arcadia Biosciences quarterly free cash flow?
- What is the all time high quarterly FCF for Arcadia Biosciences?
- What is Arcadia Biosciences quarterly FCF year-on-year change?
- What is Arcadia Biosciences TTM free cash flow?
- What is the all time high TTM FCF for Arcadia Biosciences?
- What is Arcadia Biosciences TTM FCF year-on-year change?
What is Arcadia Biosciences annual free cash flow?
The current annual FCF of RKDA is -$15.30 M
What is the all time high annual FCF for Arcadia Biosciences?
Arcadia Biosciences all-time high annual free cash flow is -$9.85 M
What is Arcadia Biosciences quarterly free cash flow?
The current quarterly FCF of RKDA is -$1.75 M
What is the all time high quarterly FCF for Arcadia Biosciences?
Arcadia Biosciences all-time high quarterly free cash flow is -$1.75 M
What is Arcadia Biosciences quarterly FCF year-on-year change?
Over the past year, RKDA quarterly free cash flow has changed by +$2.39 M (+57.73%)
What is Arcadia Biosciences TTM free cash flow?
The current TTM FCF of RKDA is -$11.58 M
What is the all time high TTM FCF for Arcadia Biosciences?
Arcadia Biosciences all-time high TTM free cash flow is -$2.13 M
What is Arcadia Biosciences TTM FCF year-on-year change?
Over the past year, RKDA TTM free cash flow has changed by +$3.72 M (+24.32%)